We've found
4,154
archived clinical trials in
Osteoarthritis (OA)
We've found
4,154
archived clinical trials in
Osteoarthritis (OA)
Adding Value in Knee Arthroplasty Post-total Knee Replacement (TKR) Care Navigator Trial
Updated: 1/16/2018
Adding Value in Knee Arthroplasty Post TKR Care Navigator Trial
Status: Enrolling
Updated: 1/16/2018
Adding Value in Knee Arthroplasty Post-total Knee Replacement (TKR) Care Navigator Trial
Updated: 1/16/2018
Adding Value in Knee Arthroplasty Post TKR Care Navigator Trial
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
The Study of Physical Activity Rewards After Knee Surgery
Status: Enrolling
Updated: 1/16/2018
Updated: 1/16/2018
The Study of Physical Activity Rewards After Knee Surgery
Status: Enrolling
Updated: 1/16/2018
Updated: 1/16/2018
Click here to add this to my saved trials
Strawberries and Knee Osteoarthritis (OA)
Updated: 1/16/2018
Effects of Freeze-dried Strawberries on Systemic Markers of Inflammation and Knee Function in Participants With Osteoarthritis (OA)
Status: Enrolling
Updated: 1/16/2018
Strawberries and Knee Osteoarthritis (OA)
Updated: 1/16/2018
Effects of Freeze-dried Strawberries on Systemic Markers of Inflammation and Knee Function in Participants With Osteoarthritis (OA)
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
Study of FX006 in Patients With Osteoarthritis of the Knee
Updated: 1/16/2018
A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 1/16/2018
Study of FX006 in Patients With Osteoarthritis of the Knee
Updated: 1/16/2018
A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
Study of FX006 in Patients With Osteoarthritis of the Knee
Updated: 1/16/2018
A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 1/16/2018
Study of FX006 in Patients With Osteoarthritis of the Knee
Updated: 1/16/2018
A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
Study of FX006 in Patients With Osteoarthritis of the Knee
Updated: 1/16/2018
A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 1/16/2018
Study of FX006 in Patients With Osteoarthritis of the Knee
Updated: 1/16/2018
A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Updated: 1/23/2018
An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Updated: 2/5/2018
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Updated: 2/5/2018
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials